Search Results - "Flieger, Dimitri"
-
1
Capecitabine and irinotecan with and without bevacizumab for advanced colorectal cancer patients
Published in World journal of gastroenterology : WJG (28-01-2009)“…AIM: To investigate the efficacy and safety of cape- citabine plus irinotecan + bevacizumab in advanced or metastatic colorectal cancer patients. METHODS:…”
Get full text
Journal Article -
2
Therapeutic vaccination against metastatic renal cell carcinoma by autologous dendritic cells: preclinical results and outcome of a first clinical phase I/II trial
Published in Cancer Immunology, Immunotherapy (01-12-2002)“…In this study we have presented in vitro data and results of a preliminary clinical trial using dendritic cells (DC) in patients with progressive metastatic…”
Get full text
Journal Article -
3
A randomized comparison of immediate versus delayed application of G-CSF in induction therapy for patients with acute myeloid leukemia unfit for intensive chemotherapy
Published in Haematologica (Roma) (01-12-2007)“…* Medizinische Klinik und Poliklinik I, Universitätsklinikum Bonn, Bonn; ° Klinikum Region Hannover, Siloah, Medizinische Klinik III, Hannover; # GPR Klinikum,…”
Get full text
Journal Article -
4
Therapeutic vaccination against metastatic carcinoma by expression-modulated and immunomodified autologous tumor cells: a first clinical phase I/II trial
Published in Human gene therapy (10-02-2001)“…Therapeutic vaccination of tumor patients with cytokine gene-transfected tumor cells leads to tumor regression in animal models but has so far not resulted in…”
Get more information
Journal Article -
5
-
6
A novel non-radioactive cellular cytotoxicity test based on the differential assessment of living and killed target and effector cells
Published in Journal of immunological methods (13-03-1995)“…Monocyte/macrophage-mediated cytotoxicity and antibody-dependent cellular cytotoxicity (ADCC) are slow processes, requiring cocultivation of effector and…”
Get full text
Journal Article -
7
Prognostic factors in nonsmall cell lung cancer: insights from the German CRISP registry
Published in The European respiratory journal (01-02-2023)“…Understanding prognosis, especially long-term outcome, in advanced nonsmall cell lung cancer (NSCLC) is crucial to inform patients, guide treatment and plan…”
Get full text
Journal Article -
8
Zn++ inhibits both tumor necrosis factor-mediated DNA fragmentation and cytolysis
Published in International journal of cancer (15-08-1989)“…The cellular events involved in direct tumor-cell destruction by tumor necrosis factor (TNF) are still incompletely understood, but a role of endonucleases has…”
Get more information
Journal Article -
9
Checkpoint Inhibitor Monotherapy in Potentially Trial-Eligible or Trial-Ineligible Patients With Metastatic NSCLC in the German Prospective CRISP Registry Real-World Cohort (AIO-TRK-0315)
Published in JTO clinical and research reports (01-04-2024)“…Patients with metastatic NSCLC (mNSCLC) treated with immune checkpoint inhibitors in clinical practice may often not meet the strict inclusion criteria of…”
Get full text
Journal Article -
10
Salvage Chemotherapy with R-DHAP in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma
Published in Cancer investigation (13-09-2016)“…This analysis reports on 72 patients with relapsed or refractory non-Hodgkin lymphoma who were treated with R-DHAP salvage chemotherapy regimen followed by…”
Get full text
Journal Article -
11
Phase II clinical trial for prevention of delayed diarrhea with cholestyramine/levofloxacin in the second-line treatment with irinotecan biweekly in patients with metastatic colorectal carcinoma
Published in Oncology (01-01-2007)“…Irinotecan is an established therapeutic option in colorectal cancer. An essential side effect of irinotecan treatment is the induction of severe WHO grade 3-4…”
Get more information
Journal Article -
12
Allogeneic dendritic cells fused with tumor cells: preclinical results and outcome of a clinical phase I/II trial in patients with metastatic renal cell carcinoma
Published in Human gene therapy (20-03-2003)“…Therapeutic vaccination with dendritic cells (DC) can lead to tumor regression in animal models and has shown promising results in the first clinical trials of…”
Get more information
Journal Article -
13
Mechanism of Cytotoxicity Induced by Chimeric Mouse Human Monoclonal Antibody IDEC-C2B8 in CD20-Expressing Lymphoma Cell Lines
Published in Cellular immunology (25-08-2000)“…With a new flow cytometric cytotoxicity assay, we examined the mechanism of action of chimeric mouse human anti-CD20 monoclonal antibody IDEC-C2B8. IDEC-C2B8…”
Get full text
Journal Article -
14
Self-expanding metal stents for malignant esophagogastric obstruction: experience with a new design covered nitinol stent
Published in Journal of gastrointestinal and liver diseases : JGLD (01-09-2007)“…Dysphagia is the most common disabling symptom in patients with inoperable esophagogastric carcinoma. Self-expanding metal stents are highly effective in the…”
Get full text
Journal Article -
15
Increase of in vivo antitumoral activity by CD40L (CD154) gene transfer into pancreatic tumor cell-dendritic cell hybrids
Published in Pancreas (01-10-2009)“…Fusion of dendritic cells (DC) with tumor cells is an approach in immunotherapy combining antigenicity and capacity of antigen presentation to activate T cells…”
Get full text
Journal Article -
16
Features of intestinal lymphoma in capsule endoscopy
Published in Gastroenterology (New York, N.Y. 1943) (01-04-2003)Get full text
Journal Article -
17
DHAP in combination with rituximab vs DHAP alone as salvage treatment for patients with relapsed or refractory diffuse large B-cell lymphoma: a matched-pair analysis
Published in Leukemia & lymphoma (01-12-2006)“…The addition of rituximab to chemotherapy in patients with diffuse large B-cell lymphoma (DLBCL) has been shown to improve outcome in first-line therapy…”
Get full text
Journal Article -
18
Dexamethasone, High-Dose Cytarabine, and Cisplatin in Combination with Rituximab as Salvage Treatment for Patients with Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
Published in Cancer investigation (01-01-2006)“…We designed a multicenter Phase II trial to prospectively evaluate the efficacy and safety of the combination of rituximab with the DHAP regimen…”
Get full text
Journal Article -
19
Identification and Characterization of a Novel Monocyte Subpopulation in Human Peripheral Blood
Published in Blood (15-11-1989)“…With the aid of two-color immunofluorescence and flow cytometry, a new subset of cells coexpressing CD14 and CD16 antigens can be identified in human…”
Get full text
Journal Article -
20
Natural cytotoxicity and antibody-dependent cellular cytotoxicity (ADCC) is not impaired in patients suffering from chronic hepatitis C
Published in Journal of hepatology (01-11-2001)“…Background/Aims : Recent observations suggest that natural killer (NK) cell activity might be impaired in chronic hepatitis C. However, to date…”
Get full text
Journal Article